Harmonized Listings: AstraZeneca's Global Stock Strategy
US is largest market with 42% sales and 18,000 staff.
Moves US trading from ADRs to ordinary shares.
Plans Virginia manufacturing and R&D in multiple US states.
Shares rose 0.7% after market reaction.
Shareholders vote on Nov 3; Neil Wilson called it a 'knock back for London'.
Board recommends harmonized listing in London, Stockholm, and NY.
3 months ago